Upright Back Posture Device Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03769246 |
Recruitment Status :
Completed
First Posted : December 7, 2018
Last Update Posted : November 5, 2019
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Back Pain Postural Low Back Pain Lower Back Pain | Device: Upright Go Device Other: Ergonomic Handout | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Supportive Care |
Official Title: | Upright Back Posture Device Study |
Actual Study Start Date : | February 8, 2018 |
Actual Primary Completion Date : | August 29, 2019 |
Actual Study Completion Date : | August 29, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Upright Go Device Group
Patients receiving the Upright device will have a brief training on the use of the device and proper posture. They will be asked to download the Upright app on their phone from the Playstore. Patients will wear the device once daily for training. They will attach the device applying an adhesive on their upper back, as instructed, and the device will be attached to the adhesive by velcro. Once completed they should remove adhesive. |
Device: Upright Go Device
Participants will be asked to use the Upright device everyday for four (4) weeks. After four (4) weeks, the participants will be asked to complete a couple of questionnaires regarding their pain scale and back posture.
Other Name: Upright Technologies |
Active Comparator: Control Group
The control group will receive a 15-20 minute instruction on proper posture by the physician and will receive an ergonomic handout.
|
Other: Ergonomic Handout
Participants will be asked to use the ergonomic handout everyday for four (4) weeks. After four (4) weeks, the participants will be asked to complete a couple of questionnaires regarding their pain scale and back posture. |
- Score on Numeric Pain Rating Scale (NPRS) [ Time Frame: 4 weeks ]The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The common format is a horizontal bar or line. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").
- Score on the PROMIS Pain Interference Short Form 6b [ Time Frame: 4 weeks ]The Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Short Form utilizes a 7-day recall period (items include the phrase "the past 7 days"). Individuals are to score pain interference for each of the 6 questions from a scale of 1 indicating 'not at all' to 5 indicating 'very much'.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Postural-related back pain
Exclusion Criteria:
- A diagnosis of significant scoliosis, herniated/bulging disc, lumbar spondylolysis, radiculitis, facet arthrosis, fibromyalgia, rheumatoid arthritis, seronegative spondyloarthropathy.
- Neurologic deficits on exam
- Currently in physical therapy (PT)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03769246
United States, New York | |
Columbia University Irving Medical Center | |
New York, New York, United States, 10032 |
Principal Investigator: | Anna-Christina Bevelaqua, M.D | Columbia University |
Responsible Party: | Anna-Christina Bevelaqua, Assistant Professor of Rehabilitation and Regenerative Medicine, Columbia University |
ClinicalTrials.gov Identifier: | NCT03769246 |
Other Study ID Numbers: |
AAAR4123 |
First Posted: | December 7, 2018 Key Record Dates |
Last Update Posted: | November 5, 2019 |
Last Verified: | November 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Device Product Not Approved or Cleared by U.S. FDA: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Upright Back Posture Back pain |
Back Pain Low Back Pain Pain Neurologic Manifestations |